Published ahead of print on September 16, 2004, doi:10.1164/rccm.200406-754OC
American Journal of Respiratory and Critical Care Medicine Vol 170. pp. 1286-1293, (2004)
© 2004 American Thoracic Society
doi: 10.1164/rccm.200406-754OC
Associated Loss of Fat-free Mass and Bone Mineral Density in Chronic Obstructive Pulmonary Disease
Charlotte E. Bolton,
Alina A. Ionescu,
Kathleen M. Shiels,
Rebecca J. Pettit,
Peter H. Edwards,
Michael D. Stone,
Lisette S. Nixon,
William D. Evans,
Timothy L. Griffiths and
Dennis J. Shale
Section of Respiratory Medicine and Communicable Diseases, and Bone Research Unit, University of Wales College of Medicine, Llandough Hospital, Penarth, Vale of Glamorgan; Department of Medical Physics and Clinical Engineering, University Hospital Wales, Heath Park, Cardiff; and Ely Bridge Surgery, Ely, Cardiff, United Kingdom
Correspondence and requests for reprints should be addressed to D. J. Shale, M.D., Section of Respiratory and Communicable Diseases, University of Wales College of Medicine, Academic Centre, Llandough Hospital, Penlan Road, Penarth, Vale of Glamorgan CF64 2XX, UK. E-mail: shaledj{at}cardiff.ac.uk
We hypothesized that in patients with chronic obstructive pulmonary disease, loss of fat-free mass (FFM) and loss of bone mineral density (BMD) were related to (1) each other and may be clinically inapparent, (2) urinary markers of cellular and bone collagen protein breakdown, and (3) severity of lung disease. Eight-one patients and 38 healthy subjects underwent dual-energy X-ray absorptiometry to determine body composition and BMD. Urinary protein breakdown markers, inflammatory mediators, and their soluble receptors were determined. Thirty-three patients had a low fat-free mass index (kg/m2), 17 of whom had a normal body mass index. Thirty-two percent of patients (13% of healthy subjects) had osteoporosis at the hip or lumbar spine. The marker of cellular protein breakdown was elevated in patients and related to lung disease severity and body composition. The marker of bone collagen breakdown was greater in patients with osteoporosis. Inflammatory mediators were elevated in patients. Loss of FFM and loss of BMD were related, occurred commonly, and could be subclinical in patients with chronic obstructive pulmonary disease. Loss of both was greatest with severe lung disease. Increased excretion of cellular and bone collagen protein breakdown products in those with low FFM and BMD indicates a protein catabolic state in these patients.
Key Words: body composition dual-energy X-ray absorptiometry osteoporosis
This article has been cited by other articles:

|
 |

|
 |
 
T. Ohara, T. Hirai, S. Muro, A. Haruna, K. Terada, D. Kinose, S. Marumo, E. Ogawa, Y. Hoshino, A. Niimi, et al.
Relationship Between Pulmonary Emphysema and Osteoporosis Assessed by CT in Patients With COPD
Chest,
December 1, 2008;
134(6):
1244 - 1249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Moss
Clinical Year in Review I: Lung Cancer, Pleural Disease, Exercise Testing and Pulmonary Rehabilitation, and Sleep Medicine
Proceedings of the ATS,
September 15, 2008;
5(7):
739 - 744.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Togo, O. Holz, X. Liu, H. Sugiura, K. Kamio, X. Wang, S. Kawasaki, Y. Ahn, K. Fredriksson, C. M. Skold, et al.
Lung Fibroblast Repair Functions in Patients with Chronic Obstructive Pulmonary Disease Are Altered by Multiple Mechanisms
Am. J. Respir. Crit. Care Med.,
August 1, 2008;
178(3):
248 - 260.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Albert and P. M. A. Calverley
Drugs (including oxygen) in severe COPD
Eur. Respir. J.,
May 1, 2008;
31(5):
1114 - 1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. M. Chatila, B. M. Thomashow, O. A. Minai, G. J. Criner, and B. J. Make
Comorbidities in Chronic Obstructive Pulmonary Disease
Proceedings of the ATS,
May 1, 2008;
5(4):
549 - 555.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al.
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Eur. Respir. J.,
February 1, 2008;
31(2):
416 - 469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R A Stockley
Biomarkers in COPD: time for a deep breath
Thorax,
August 1, 2007;
62(8):
657 - 660.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Vogelmeier and R. Bals
Chronic Obstructive Pulmonary Disease and Premature Aging
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1217 - 1218.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Sabit, C. E. Bolton, P. H. Edwards, R. J. Pettit, W. D. Evans, C. M. McEniery, I. B. Wilkinson, J. R. Cockcroft, and D. J. Shale
Arterial Stiffness and Osteoporosis in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
June 15, 2007;
175(12):
1259 - 1265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vestbo
Systemic inflammation and progression of COPD
Thorax,
June 1, 2007;
62(6):
469 - 470.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E Bolton, R. Broekhuizen, A. A Ionescu, L. S Nixon, E. F M Wouters, D. J Shale, and A. M W J Schols
Cellular protein breakdown and systemic inflammation are unaffected by pulmonary rehabilitation in COPD
Thorax,
February 1, 2007;
62(2):
109 - 114.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. J. Langen, A. M. W. J. Schols, M. C. J. M. Kelders, J. L. J. van der Velden, E. F. M. Wouters, and Y. M. W. Janssen-Heininger
Muscle Wasting and Impaired Muscle Regeneration in a Murine Model of Chronic Pulmonary Inflammation
Am. J. Respir. Cell Mol. Biol.,
December 1, 2006;
35(6):
689 - 696.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. Shead, C. S. Haworth, E. Gunn, D. Bilton, M. A. Scott, and J. E. Compston
Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis
Am. J. Respir. Crit. Care Med.,
August 1, 2006;
174(3):
306 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. M. Wouters
Approaches to Improving Health Status in Chronic Obstructive Pulmonary Disease: One or Several?
Proceedings of the ATS,
May 1, 2006;
3(3):
262 - 269.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. F. M. Wouters
Muscle Wasting in Chronic Obstructive Pulmonary Disease: To Bother and to Measure!
Am. J. Respir. Crit. Care Med.,
January 1, 2006;
173(1):
4 - 5.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Vestbo, E. Prescott, T. Almdal, M. Dahl, B. G. Nordestgaard, T. Andersen, T. I. A. Sorensen, and P. Lange
Body Mass, Fat-Free Body Mass, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease from a Random Population Sample: Findings from the Copenhagen City Heart Study
Am. J. Respir. Crit. Care Med.,
January 1, 2006;
173(1):
79 - 83.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Broekhuizen, R. F Grimble, W M. Howell, D. J Shale, E. C Creutzberg, E. F Wouters, and A. M Schols
Pulmonary cachexia, systemic inflammatory profile, and the interleukin 1{beta} -511 single nucleotide polymorphism
Am. J. Clinical Nutrition,
November 1, 2005;
82(5):
1059 - 1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Van Vliet, M. A. Spruit, G. Verleden, A. Kasran, E. Van Herck, F. Pitta, R. Bouillon, and M. Decramer
Hypogonadism, Quadriceps Weakness, and Exercise Intolerance in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med.,
November 1, 2005;
172(9):
1105 - 1111.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Barnes and R. A. Stockley
COPD: current therapeutic interventions and future approaches
Eur. Respir. J.,
June 1, 2005;
25(6):
1084 - 1106.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. de Vries, T. P. van Staa, M. S. G. M. Bracke, C. Cooper, H. G. M. Leufkens, and J-W. J. Lammers
Severity of obstructive airway disease and risk of osteoporotic fracture
Eur. Respir. J.,
May 1, 2005;
25(5):
879 - 884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fabbri, S. P. Peters, I. Pavord, S. E. Wenzel, S. C. Lazarus, W. MacNee, F. Lemaire, and E. Abraham
Allergic Rhinitis, Asthma, Airway Biology, and Chronic Obstructive Pulmonary Disease in AJRCCM in 2004
Am. J. Respir. Crit. Care Med.,
April 1, 2005;
171(7):
686 - 698.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Sethi
Musculoskeletal Effects of Chronic Obstructive Pulmonary Disease: Prevalent, Linked, but Ignored
Am. J. Respir. Crit. Care Med.,
December 15, 2004;
170(12):
1267 - 1268.
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society
|
|
|